Role of patient advocacy stakeholders in science-based regulatory policy at the U.S. Food and Drug Administration (FDA)
The inclusion of the patients voice when developing regulatory policy is a burgeoning area of policy practice. The influence of patient advocacy organizations and individual patients on the formation of science-based regulatory policy at the Food and Drug Administration (FDA) has increased dramatic...
| Published: |
|
|---|---|
| Online Access: | http://hdl.handle.net/2047/D20280899 |